Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB293247

Adenylosuccinate Lyase Antibody (05), DyLight 594, Novus Biologicals™
SDP

Catalog No. NB293247 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB293247 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB293247 Supplier Novus Biologicals Supplier No. NBP326085DL594
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Adenylosuccinate Lyase Monoclonal antibody specifically detects Adenylosuccinate Lyase in Human samples. It is validated for Immunocytochemistry

Specifications

Antigen Adenylosuccinate Lyase
Applications Immunocytochemistry
Classification Monoclonal
Clone 05
Conjugate DyLight 594
Dilution Immunocytochemistry
Formulation 50mM Sodium Borate
Gene Alias adenylosuccinase, adenylosuccinate lyase, AMPS, ASase, ASL, EC 4.3.2, EC 4.3.2.2
Host Species Mouse
Immunogen This product is a recombinant monoclonal antibody expressed from HEK293 cells.
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Core ESC Like Genes, Stem Cell Markers
Primary or Secondary Primary
Gene ID (Entrez) 158
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.